OPSEU Pension Plan Trust Fund lifted its position in CME Group Inc. (NASDAQ:CME) by 10.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,957 shares of the financial services provider’s stock after buying an additional 1,033 shares during the period. OPSEU Pension Plan Trust Fund’s holdings in CME Group were worth $1,857,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Stanley Laman Group Ltd. increased its holdings in CME Group by 1.3% in the 2nd quarter. Stanley Laman Group Ltd. now owns 12,236 shares of the financial services provider’s stock valued at $1,989,000 after purchasing an additional 159 shares during the last quarter. Empirical Finance LLC raised its holdings in CME Group by 14.6% in the 2nd quarter. Empirical Finance LLC now owns 2,343 shares of the financial services provider’s stock valued at $381,000 after acquiring an additional 299 shares during the last quarter. SG Americas Securities LLC lifted its position in CME Group by 224.7% during the second quarter. SG Americas Securities LLC now owns 40,308 shares of the financial services provider’s stock worth $6,552,000 after buying an additional 72,634 shares during the period. Robeco Institutional Asset Management B.V. grew its position in CME Group by 40.2% during the second quarter. Robeco Institutional Asset Management B.V. now owns 289,057 shares of the financial services provider’s stock valued at $46,983,000 after acquiring an additional 82,831 shares during the period. Finally, Davis R M Inc. grew its position in CME Group by 7.0% in the second quarter. Davis R M Inc. now owns 134,476 shares of the financial services provider’s stock valued at $21,858,000 after acquiring an additional 8,808 shares in the last quarter. 84.24% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Ken Vroman sold 4,541 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $152.63, for a total transaction of $693,092.83. Following the completion of the transaction, the insider now owns 9,879 shares of the company’s stock, valued at $1,507,831.77. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 5,000 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $173.52, for a total value of $867,600.00. In the last quarter, insiders sold 11,541 shares of company stock valued at $1,909,913. Company insiders own 1.20% of the company’s stock.
NASDAQ CME traded down $2.62 during trading hours on Tuesday, reaching $166.15. The company’s stock had a trading volume of 15,675 shares, compared to its average volume of 1,970,221. The stock has a market cap of $60.59 billion, a P/E ratio of 28.13, a P/E/G ratio of 12.10 and a beta of 0.37. The firm has a fifty day simple moving average of $162.72 and a 200-day simple moving average of $170.34. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52 week low of $131.80 and a 52 week high of $225.36.
CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 28th. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.41 by ($0.03). CME Group had a net margin of 43.68% and a return on equity of 9.22%. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same quarter in the previous year, the firm earned $1.90 EPS. On average, research analysts expect that CME Group Inc. will post 6.75 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Thursday, December 10th will be issued a dividend of $0.85 per share. This represents a $3.40 annualized dividend and a yield of 2.05%. The ex-dividend date of this dividend is Wednesday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 50.00%.
A number of analysts have recently weighed in on CME shares. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $167.00 to $187.00 and gave the stock a “buy” rating in a research report on Wednesday, November 11th. Rosenblatt Securities reduced their price objective on shares of CME Group from $141.00 to $139.00 and set a “sell” rating for the company in a report on Wednesday, November 4th. Credit Suisse Group raised their target price on shares of CME Group from $170.00 to $177.00 and gave the company a “neutral” rating in a research note on Thursday, September 10th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a report on Tuesday, September 29th. Finally, Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $176.00 to $195.00 in a research report on Wednesday, September 23rd. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $183.35.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.
Featured Story: Day Trading
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.